Literature DB >> 11454650

Effect of cyclosporin A and its vehicle on cardiac and skeletal muscle mitochondria: relationship to efficacy of the respiratory chain.

H Sanchez1, J Zoll, X Bigard, V Veksler, B Mettauer, E Lampert, J Lonsdorfer, R Ventura-Clapier.   

Abstract

Although cyclosporin (CsA) is considered to be the best immunosuppressive molecule in transplantation, it has been suspected to alter mitochondrial respiration of various tissues. We evaluated the acute effect of CsA and its vehicle on maximal oxidative capacity (V(max)) of cardiac, soleus and gastrocnemius muscles of rats by an oxygraphic method in saponin skinned muscle fibres. The effects of Sandimmun (a formulation of CsA), vehicle of Sandimmun (cremophor and ethanol (EtOH)), CsA in EtOH and EtOH alone were tested. Increasing concentrations (5 - 20 - 50 - 100 microM) of CsA (or vehicles) were used. Sandimmun profoundly altered the V(max) of all muscles. For example, at 20 microM, inhibition reached 18+/-3, 23+/-5, 45+/-5%, for heart, soleus and gastrocnemius respectively. There were only minor effects of CsA diluted in EtOH and EtOH alone on V(max) of cardiac muscle. Because the effects of vehicle on V(max) were similar or higher than those of Sandimmun, the inhibition of oxidative capacity could be entirely attributed to the vehicle for all muscles. Next, we investigated the potential sites of action of the vehicle on the different complexes of the mitochondrial respiratory chain by using specific substrates and inhibitors. The vehicle affected mitochondrial respiration mainly at the level of complex I ( approximately -85% in skeletal muscles, and -32% in heart), but also at complex IV ( approximately -26% for all muscles). The mechanism of action of the vehicle on the mitochondrial membrane and the implications for the clinical use of immunosuppressive drugs are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454650      PMCID: PMC1572839          DOI: 10.1038/sj.bjp.0704129

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Mitochondrial myopathy studies on permeabilized muscle fibers.

Authors:  T Letellier; M Malgat; M Coquet; B Moretto; F Parrot-Roulaud; J P Mazat
Journal:  Pediatr Res       Date:  1992-07       Impact factor: 3.756

2.  Cyclosporin A and vehicle toxicity in primary cultures of rabbit renal proximal tubule cells.

Authors:  P P Sokol; L C Capodagli; M Dixon; P D Holohan; C R Ross; R Coulson; D B Jones
Journal:  Am J Physiol       Date:  1990-12

3.  Inhibition of fatty acid-supported mitochondrial respiration by cyclosporine.

Authors:  C A Lemmi; R L Miller; J Rajfer
Journal:  Biochem Med Metab Biol       Date:  1990-12

4.  Metabolic control analysis and mitochondrial pathologies.

Authors:  T Letellier; M Malgat; R Rossignol; J P Mazat
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

5.  Mechanisms of ciclosporin A-induced vasoconstriction in the isolated perfused rat kidney.

Authors:  N Mehring; K H Neumann; K H Rahn; W Zidek
Journal:  Nephron       Date:  1992       Impact factor: 2.847

6.  The hemodynamic effects of Cremophor-EL.

Authors:  V D Bowers; S Locker; S Ames; W Jennings; R J Corry
Journal:  Transplantation       Date:  1991-04       Impact factor: 4.939

7.  Effect of cyclosporin A and different vehicles on ATP production in mitochondria isolated from the rat kidney cortex.

Authors:  L Nässberger
Journal:  Pharmacol Toxicol       Date:  1990-08

8.  Evolution of energy metabolism. Proton permeability of the inner membrane of liver mitochondria is greater in a mammal than in a reptile.

Authors:  M D Brand; P Couture; P L Else; K W Withers; A J Hulbert
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

9.  The influence of the cyclosporine vehicle, cremophor EL, on renal microvascular blood flow in the rat.

Authors:  J S Abraham; F R Bentley; R N Garrison; H M Cryer
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

10.  Cholestasis in the rat by means of intravenous administration of cyclosporine vehicle, Cremophor EL.

Authors:  I D Roman; M J Monte; A Esteller; R Jimenez
Journal:  Transplantation       Date:  1989-10       Impact factor: 4.939

View more
  13 in total

1.  Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes.

Authors:  Victor G Sharov; Anastassia V Todor; Makoto Imai; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

2.  Use of Six-Minute Walk Test to Measure Functional Capacity After Liver Transplantation.

Authors:  Lisa B VanWagner; Sarah Uttal; Brittany Lapin; Joshua Lee; Amanda Jichlinski; Tanvi Subramanian; Madeleine Heldman; Brian Poole; Eduardo Bustamante; Suvai Gunasekaran; Christopher S Tapia; Annapoorani Veerappan; She-Yan Wong; Josh Levitsky
Journal:  Phys Ther       Date:  2016-04-07

3.  Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via ROS generation, iNOS and Hsp70.

Authors:  Huei-Wen Chen; Chiang-Ting Chien; Sung-Liang Yu; Yuan-Teh Lee; Wen-Jone Chen
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  In vivo opening of the mitochondrial permeability transition pore in a rat model of ventricular fibrillation and closed-chest resuscitation.

Authors:  Iyad M Ayoub; Jeejabai Radhakrishnan; Raúl J Gazmuri
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

5.  Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A.

Authors:  Jacqueline R Kulbe; Rachel L Hill; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2016-10-13       Impact factor: 5.269

6.  Calcineurin is not involved in some mitochondrial enzyme adaptations to endurance exercise training in rat skeletal muscle.

Authors:  Shin Terada; Hisashi Nakagawa; Yoshio Nakamura; Isao Muraoka
Journal:  Eur J Appl Physiol       Date:  2003-07-10       Impact factor: 3.078

7.  Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.

Authors:  S M Gardiner; J E March; P A Kemp; B Fallgren; T Bennett
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

8.  Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.

Authors:  J Reutenauer; O M Dorchies; O Patthey-Vuadens; G Vuagniaux; U T Ruegg
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

9.  Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination.

Authors:  Ya-Wen Yang; Meng-Kun Tsai; Ching-Yao Yang; Chih-Yuan Lee; Bor-Luen Chiang; Hong-Shiee Lai
Journal:  Clin Exp Nephrol       Date:  2020-03-26       Impact factor: 2.801

10.  Apparent Km of mitochondria for oxygen computed from Vmax measured in permeabilized muscle fibers is lower in water enriched in oxygen by electrolysis than injection.

Authors:  Joffrey Zoll; Jamal Bouitbir; Pascal Sirvent; Alexis Klein; Antoine Charton; Liliana Jimenez; François R Péronnet; Bernard Geny; Ruddy Richard
Journal:  Drug Des Devel Ther       Date:  2015-07-13       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.